Cargando…

Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies

Herpes viruses persist in the infected host and are transmitted between hosts in the presence of a fully functional humoral immune response, suggesting that they can evade neutralization by antiviral antibodies. Human cytomegalovirus (HCMV) encodes a number of polymorphic highly glycosylated virion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kropff, Barbara, Burkhardt, Christiane, Schott, Juliane, Nentwich, Jens, Fisch, Tanja, Britt, William, Mach, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486915/ https://www.ncbi.nlm.nih.gov/pubmed/23133379 http://dx.doi.org/10.1371/journal.ppat.1002999

Ejemplares similares

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
por: Bootz, Anna, et al.
Publicado: (2017)

Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
por: Reuter, Nina, et al.
Publicado: (2022)

Differences in Growth Properties among Two Human Cytomegalovirus Glycoprotein O Genotypes
por: Kalser, Julia, et al.
Publicado: (2017)

B Cell Repertoire Analysis Identifies New Antigenic Domains on Glycoprotein B of Human Cytomegalovirus which Are Target of Neutralizing Antibodies
por: Pötzsch, Sonja, et al.
Publicado: (2011)

Human Cytomegalovirus Envelope Protein gpUL132 Regulates Infectious Virus Production through Formation of the Viral Assembly Compartment
por: Wu, Hui, et al.
Publicado: (2020)

Structural Basis for the Recognition of Human Cytomegalovirus Glycoprotein B by a Neutralizing Human Antibody
por: Spindler, Nadja, et al.
Publicado: (2014)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia
por: Baraniak, Ilona, et al.
Publicado: (2018)

Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L
por: He, Li, et al.
Publicado: (2022)

Detection of antibody-secreting cells specific for the cytomegalovirus and herpes simplex virus surface antigens
por: Alt, Mira, et al.
Publicado: (2018)

Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection
por: Brouwer, Philip J.M., et al.
Publicado: (2022)

SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
por: Reuter, Nina, et al.
Publicado: (2023)

A fully human neutralizing monoclonal antibody targeting a highly conserved epitope of the human cytomegalovirus glycoprotein B
por: Okamoto, Miwa, et al.
Publicado: (2023)

IgA binds to the AD‐2 epitope of glycoprotein B and neutralizes human cytomegalovirus
por: Siddiqui, Saima, et al.
Publicado: (2020)

Murine cytomegalovirus reactivation concomitant with acute graft-versus-host disease is controlled by antibodies
por: Seefried, Martina, et al.
Publicado: (2023)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection
por: Semmes, Eleanor C., et al.
Publicado: (2022)

Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus
por: Su, Hang, et al.
Publicado: (2021)

Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodies
por: Perrett, Hailee R., et al.
Publicado: (2023)

Human cytomegalovirus glycoprotein N polymorphisms among renal transplant recipients in India
por: Patro, A Raj Kumar, et al.
Publicado: (2014)

Development of two potential diagnostic monoclonal antibodies against human cytomegalovirus glycoprotein B
por: Fan, Jun, et al.
Publicado: (2012)

Cytomegalovirus Genotype Distribution among Postnatally Infected Infants: Association of Glycoprotein B, Glycoprotein N and Glycoprotein H Types with CMV-Associated Thrombocytopenia
por: Hu, Hongbo, et al.
Publicado: (2020)

Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
por: Li, Fengsheng, et al.
Publicado: (2017)

Human cytomegalovirus glycoprotein complex gH/gL/gO uses PDGFR-α as a key for entry
por: Wu, Yiquan, et al.
Publicado: (2017)

A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
por: Kuraoka, Masayuki, et al.
Publicado: (2023)

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
por: Bisht, Himani, et al.
Publicado: (2005)

HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
por: van den Kerkhof, Tom L. G. M., et al.
Publicado: (2016)

Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas
por: Tabata, Takako, et al.
Publicado: (2019)

Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH
por: Parsons, Andrea J., et al.
Publicado: (2022)

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
por: Torrents de la Peña, Alba, et al.
Publicado: (2018)

Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells
por: Hong, Junping, et al.
Publicado: (2022)

Crystal Structure of the Human Cytomegalovirus Glycoprotein B
por: Burke, Heidi G., et al.
Publicado: (2015)

Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine
por: Arav-Boger, Ravit, et al.
Publicado: (2012)

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera
por: Luo, Yong, et al.
Publicado: (2016)

The Human Cytomegalovirus Nonstructural Glycoprotein UL148 Reorganizes the Endoplasmic Reticulum
por: Zhang, Hongbo, et al.
Publicado: (2019)

Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein
por: Grunst, Michael W., et al.
Publicado: (2023)

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

Measles Virus Glycoprotein-Based Lentiviral Targeting Vectors That Avoid Neutralizing Antibodies
por: Kneissl, Sabrina, et al.
Publicado: (2012)

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
por: Janus, Benjamin M., et al.
Publicado: (2018)

Characterization of Single-Chain Fv Fragments of Neutralizing Antibodies to Rabies Virus Glycoprotein
por: Yumoto, Kohei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4h2s66pdetsofptfpq50q60p4j